Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Tonga: Prevalence of current tobacco use, males

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
34.9%
in 2024
Tonga
47.9%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
18th
Tonga rank
19th

Prevalence of current tobacco use, males over time

  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
  • Tonga
0204060200020122024

How they compare

Tonga currently reports 47.9% against 34.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 13.0%.

That makes Tonga's figure about 1.4 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 9 years both countries report, Tonga has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Tonga ranks 19th of 46 groups.

Tonga has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Tonga Difference Ahead
2000s 43.8% 51.7% 7.9% Tonga
2010s 39.1% 50.0% 10.9% Tonga
2020s 35.4% 48.1% 12.7% Tonga

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of current tobacco use, males, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Tonga?
Tonga, at 47.9% against 34.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
What is the difference in prevalence of current tobacco use, males between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tonga?
13.0%, with Tonga ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tonga?
9 years are reported by both, from 2000 to 2024.
How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tonga rank globally for prevalence of current tobacco use, males?
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Tonga ranks 19th of 46 groups.
Where does this data come from?
Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Tonga: Prevalence of current tobacco use, males. Statizoid, drawing on Global Health Observatory Data Repository, World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/prevalence-of-current-tobacco-use-males-percent-of-male-adults/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/prevalence-of-current-tobacco-use-males-percent-of-male-adults/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/tonga/">Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Tonga: Prevalence of current tobacco use, males</a> — Statizoid

About this data

Indicator
Prevalence of current tobacco use, males (% of male adults)
Unit
% of male adults
Source
Global Health Observatory Data Repository, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
212 places, 1,908 data points, 2000–2024
Last refreshed

The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.